Ipamorelin is notable for its specificity in GH release, avoiding unwanted side effects such as cortisol elevation, which is common with other GH secretagogues
Confirmed at 28 days A follow-up 28-day study (Babula et al., 2024) extended the finding: 5-Amino-1MQ dose-dependently limited body weight and fat mass gain without changing food intake, and it improved liver markers in obese mice
Is the KLOW peptide blend third-party tested
PubMed Jensen, L., Helleberg, H., Roffel, A., van Lier, J.J.,Bjrnsdottir, I., Pedersen, P.J., Rowe, E., Derving Karsbl, J., & Pedersen, M.L
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults